Renal glutathione depletion and nephrotoxicity of cadmium-metallothionein in rats.

Renal glutathione (GSH) concentrations were reduced approximately 80% at 4 hr after a single injection of buthionine sulfoxime (BSO) (4 mmol/kg body wt) and remained reduced for at least 16 hr in male rats. Following BSO injection, rats were injected with a nephrotoxic dose of cadmium-metallothionein (Cd-MT) (0.3 mg Cd as Cd-MT/kg body wt) and killed 1, 4, or 12 hr later. Damage to the kidney was assessed histologically and by measurement of p-aminohippuric acid (PAH) uptake into renal cortical slices. Although the renal accumulation of Cd following Cd-MT injection was significantly lower in BSO-pretreated rats as compared to nonpretreated rats, the damage to kidney was more severe. At 4 and 12 hr, both Cd-MT-induced inhibition of PAH uptake and morphological damage were significantly increased in BSO-pretreated rats. In certain experiments, the induction of renal intracellular MT synthesis by zinc pretreatment slightly decreased the renal toxicity of Cd-MT in the BSO-treated rats. The results demonstrate that although GSH depletion decreases the renal accumulation of Cd in rats injected with Cd-MT, the nephrotoxicity of Cd-MT is increased. Preinduction of MT in the kidney can only partially overcome this increase in toxicity. Therefore both GSH and intracellular MT levels can influence the renal toxicity of injected Cd-MT.

[1]  M. George,et al.  Cadmium-metallothionein-induced nephropathy☆☆☆ , 1976 .

[2]  W. Braselton,et al.  Effects of vanadate on organic ion accumulation in rat renal cortical slices. , 1982, The Journal of pharmacology and experimental therapeutics.

[3]  M. M. Elías,et al.  Rat kidney function related to tissue glutathione levels. , 1986, Biochemical pharmacology.

[4]  A. Meister,et al.  Glutathione, a first line of defense against cadmium toxicity , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  B. Fowler,et al.  Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding. , 1984, The Journal of pharmacology and experimental therapeutics.

[6]  A. Scheuhammer,et al.  Quantification of metallothioneins by a silver-saturation method. , 1986, Toxicology and applied pharmacology.

[7]  D. Templeton,et al.  Chemical modifications of metallothionein. Preparation and characterization of polymers. , 1984, The Biochemical journal.

[8]  M. Cherian.  The synthesis of metallothionein and cellular adaptation to metal toxicity in primary rat kidney epithelial cell cultures. , 1980, Toxicology.

[9]  A. Meister,et al.  Glutathione and related gamma-glutamyl compounds: biosynthesis and utilization. , 1976, Annual review of biochemistry.

[10]  B. Fowler,et al.  The renal toxicity of cadmium metallothionein: morphometric and X-ray microanalytical studies. , 1978, Toxicology and applied pharmacology.

[11]  F. Tietze.  Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. , 1969, Analytical biochemistry.

[12]  A. Meister,et al.  Glutathione: interorgan translocation, turnover, and metabolism. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. W. Smith,et al.  THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. , 1945, The Journal of clinical investigation.

[14]  J. C. Smith,et al.  The mechanisms of hepatic and renal metallothionein biosynthesis in cadmium-exposed rats. , 1977, Chemico-biological interactions.

[15]  M. Nordberg,et al.  Comparative toxicity of cadmium-metallothionein and cadmium chloride on mouse kidney. , 1975, Archives of pathology.

[16]  M. Cempel,et al.  The time-course of cadmium-thionein synthesis in the rat. , 1976, Biochemical pharmacology.

[17]  C. Klaassen,et al.  Tolerance to cadmium-induced hepatotoxicity following cadmium pretreatment. , 1984, Toxicology and applied pharmacology.

[18]  S. Onosaka,et al.  Fate of 109Cd-labeled metallothionein in rats. , 1975, Toxicology and applied pharmacology.

[19]  J. Taggart,et al.  Renal tubular transport: accumulation of p-aminohippurate by rabbit kidney slices. , 1950, The American journal of physiology.

[20]  Cousins Rj,et al.  Control of cadmium binding protein synthesis in rat liver. , 1974 .

[21]  Cherian Mg.  Studies on toxicity of metallothionein in rat kidney epithelial cell culture. , 1982 .

[22]  R. Verschoyle,et al.  An investigation of the role of metallothioneins in protection against the acute toxicity of the cadmium ion. , 1976, Biochemical pharmacology.

[23]  M. Cherian,et al.  Metabolism of intravenously injected cadmium-binding protein. , 1975, Biochemical and biophysical research communications.

[24]  C. E. Hildebrand,et al.  Molecular mechanisms of cadmium detoxification in cadmium-resistant cultured cells: role of metallothionein and other inducible factors. , 1982, Developments in toxicology and environmental science.

[25]  D. D. Perrin,et al.  Complex formation of zinc and cadmium with glutathione. , 1971, Biochimica et biophysica acta.

[26]  W. Berndt,et al.  The effect of depletion of nonprotein sulfhydryls by diethyl maleate plus buthionine sulfoximine on renal uptake of mercury in the rat. , 1986, Toxicology and applied pharmacology.